Harrow Health, Inc. beat EPS estimates 50% of the time across 16 reported quarters (8 beats, 8 misses), averaging +0.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.23 | $-0.34 | -47.8% | Miss | Q2 FY26 call |
| Q1 FY26 | $-0.43 | $-0.63 | -46.5% | Miss | Q1 FY26 call |
| Q4 FY25 | $0.40 | $0.26 | -35.0% | Miss | |
| Q3 FY25 | $0.22 | $0.33 | +50.0% | Beat | |
| Q2 FY25 | $0.00 | $0.24 | not reported | Beat | |
| Q1 FY25 | not reported | $-0.38 | not reported | not reported | |
| Q4 FY24 | $0.11 | $0.25 | +127.3% | Beat | |
| Q3 FY24 | $-0.05 | $-0.12 | -140.0% | Miss | |
| Q2 FY24 | $-0.25 | $-0.13 | +48.0% | Beat | |
| Q1 FY24 | $-0.25 | $-0.28 | -12.0% | Miss | |
| Q4 FY23 | not reported | $-0.27 | not reported | not reported | |
| Q3 FY23 | not reported | $-0.09 | not reported | not reported |
Back to HROW overview · HROW holders · HROW KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.